Investigating antimalarial drug interactions of emetine dihydrochloride hydrate using CalcuSyn-based interactivity calculations.
The widespread introduction of artemisinin-based combination therapy has contributed to recent reductions in malaria mortality. Combination therapies have a range of advantages, including synergism, toxicity reduction, and delaying the onset of resistance acquisition. Unfortunately, antimalarial com...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC5336292?pdf=render |
| _version_ | 1811276951285923840 |
|---|---|
| author | Holly Matthews Jon Deakin May Rajab Maryam Idris-Usman Niroshini J Nirmalan |
| author_facet | Holly Matthews Jon Deakin May Rajab Maryam Idris-Usman Niroshini J Nirmalan |
| author_sort | Holly Matthews |
| collection | DOAJ |
| description | The widespread introduction of artemisinin-based combination therapy has contributed to recent reductions in malaria mortality. Combination therapies have a range of advantages, including synergism, toxicity reduction, and delaying the onset of resistance acquisition. Unfortunately, antimalarial combination therapy is limited by the depleting repertoire of effective drugs with distinct target pathways. To fast-track antimalarial drug discovery, we have previously employed drug-repositioning to identify the anti-amoebic drug, emetine dihydrochloride hydrate, as a potential candidate for repositioned use against malaria. Despite its 1000-fold increase in in vitro antimalarial potency (ED50 47 nM) compared with its anti-amoebic potency (ED50 26-32 uM), practical use of the compound has been limited by dose-dependent toxicity (emesis and cardiotoxicity). Identification of a synergistic partner drug would present an opportunity for dose-reduction, thus increasing the therapeutic window. The lack of reliable and standardised methodology to enable the in vitro definition of synergistic potential for antimalarials is a major drawback. Here we use isobologram and combination-index data generated by CalcuSyn software analyses (Biosoft v2.1) to define drug interactivity in an objective, automated manner. The method, based on the median effect principle proposed by Chou and Talalay, was initially validated for antimalarial application using the known synergistic combination (atovaquone-proguanil). The combination was used to further understand the relationship between SYBR Green viability and cytocidal versus cytostatic effects of drugs at higher levels of inhibition. We report here the use of the optimised Chou Talalay method to define synergistic antimalarial drug interactivity between emetine dihydrochloride hydrate and atovaquone. The novel findings present a potential route to harness the nanomolar antimalarial efficacy of this affordable natural product. |
| first_indexed | 2024-04-13T00:06:57Z |
| format | Article |
| id | doaj.art-7ca2fc5a46004a8e9ef0c676cbc75aff |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-13T00:06:57Z |
| publishDate | 2017-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-7ca2fc5a46004a8e9ef0c676cbc75aff2022-12-22T03:11:12ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01123e017330310.1371/journal.pone.0173303Investigating antimalarial drug interactions of emetine dihydrochloride hydrate using CalcuSyn-based interactivity calculations.Holly MatthewsJon DeakinMay RajabMaryam Idris-UsmanNiroshini J NirmalanThe widespread introduction of artemisinin-based combination therapy has contributed to recent reductions in malaria mortality. Combination therapies have a range of advantages, including synergism, toxicity reduction, and delaying the onset of resistance acquisition. Unfortunately, antimalarial combination therapy is limited by the depleting repertoire of effective drugs with distinct target pathways. To fast-track antimalarial drug discovery, we have previously employed drug-repositioning to identify the anti-amoebic drug, emetine dihydrochloride hydrate, as a potential candidate for repositioned use against malaria. Despite its 1000-fold increase in in vitro antimalarial potency (ED50 47 nM) compared with its anti-amoebic potency (ED50 26-32 uM), practical use of the compound has been limited by dose-dependent toxicity (emesis and cardiotoxicity). Identification of a synergistic partner drug would present an opportunity for dose-reduction, thus increasing the therapeutic window. The lack of reliable and standardised methodology to enable the in vitro definition of synergistic potential for antimalarials is a major drawback. Here we use isobologram and combination-index data generated by CalcuSyn software analyses (Biosoft v2.1) to define drug interactivity in an objective, automated manner. The method, based on the median effect principle proposed by Chou and Talalay, was initially validated for antimalarial application using the known synergistic combination (atovaquone-proguanil). The combination was used to further understand the relationship between SYBR Green viability and cytocidal versus cytostatic effects of drugs at higher levels of inhibition. We report here the use of the optimised Chou Talalay method to define synergistic antimalarial drug interactivity between emetine dihydrochloride hydrate and atovaquone. The novel findings present a potential route to harness the nanomolar antimalarial efficacy of this affordable natural product.http://europepmc.org/articles/PMC5336292?pdf=render |
| spellingShingle | Holly Matthews Jon Deakin May Rajab Maryam Idris-Usman Niroshini J Nirmalan Investigating antimalarial drug interactions of emetine dihydrochloride hydrate using CalcuSyn-based interactivity calculations. PLoS ONE |
| title | Investigating antimalarial drug interactions of emetine dihydrochloride hydrate using CalcuSyn-based interactivity calculations. |
| title_full | Investigating antimalarial drug interactions of emetine dihydrochloride hydrate using CalcuSyn-based interactivity calculations. |
| title_fullStr | Investigating antimalarial drug interactions of emetine dihydrochloride hydrate using CalcuSyn-based interactivity calculations. |
| title_full_unstemmed | Investigating antimalarial drug interactions of emetine dihydrochloride hydrate using CalcuSyn-based interactivity calculations. |
| title_short | Investigating antimalarial drug interactions of emetine dihydrochloride hydrate using CalcuSyn-based interactivity calculations. |
| title_sort | investigating antimalarial drug interactions of emetine dihydrochloride hydrate using calcusyn based interactivity calculations |
| url | http://europepmc.org/articles/PMC5336292?pdf=render |
| work_keys_str_mv | AT hollymatthews investigatingantimalarialdruginteractionsofemetinedihydrochloridehydrateusingcalcusynbasedinteractivitycalculations AT jondeakin investigatingantimalarialdruginteractionsofemetinedihydrochloridehydrateusingcalcusynbasedinteractivitycalculations AT mayrajab investigatingantimalarialdruginteractionsofemetinedihydrochloridehydrateusingcalcusynbasedinteractivitycalculations AT maryamidrisusman investigatingantimalarialdruginteractionsofemetinedihydrochloridehydrateusingcalcusynbasedinteractivitycalculations AT niroshinijnirmalan investigatingantimalarialdruginteractionsofemetinedihydrochloridehydrateusingcalcusynbasedinteractivitycalculations |